DALVANCE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
57970-100 -
Package NDC
57970-100-01 -
Application number
NDA021883 -
SPL ID
c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab -
SPL set ID
4b4674d8-4d1e-4728-8465-d42ada33fa5c -
UNII
33WDQ7T81E -
RxCUI
1539243 -
RxCUI
1539248
What the source publishes
- Labeler
- Allergan, Inc.
- Active ingredients
- Dalbavancin
- Form
- INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DALVANCE",
"splId": "c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab",
"labels": [
{
"setId": "4b4674d8-4d1e-4728-8465-d42ada33fa5c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b4674d8-4d1e-4728-8465-d42ada33fa5c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b4674d8-4d1e-4728-8465-d42ada33fa5c"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Allergan, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL",
"package_ndc": "57970-100-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20140523"
}
],
"productId": "57970-100_c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, FOR SOLUTION",
"productNdc": "57970-100",
"deaSchedule": null,
"genericName": "Dalbavancin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DALBAVANCIN HYDROCHLORIDE",
"strength": "500 mg/25mL"
}
],
"applicationNumber": "NDA021883",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140523",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"33WDQ7T81E"
],
"rxcui": [
"1539243",
"1539248"
],
"spl_set_id": [
"4b4674d8-4d1e-4728-8465-d42ada33fa5c"
],
"manufacturer_name": [
"Allergan, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:57970-100_c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab"